Explore the future of cancer treatment with Dr. Loren Walensky, a 2022 Harrington Scholar-Innovator from the Dana-Farber Cancer Institute. Dr. Walensky is changing the landscape of oncology with a focus on treatment-resistant cancers in both children and adults. Dr. Walensky unveils a groundbreaking approach to cancer therapy that leverages stapled peptide proteolysis-targeting chimera (SP-PROTAC) technology. This innovative method aims to simultaneously reactivate the p53 pathway and degrade cancer-causing proteins, empowering our cells to combat cancer from within.
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio was created in 2012 to fulfill its mission “To accelerate promising discoveries into medicines for unmet needs.” Learn more: [ Ссылка ]
University Hospitals is one of the nation’s leading health care systems, providing patient-centered care that meets the highest standards for quality and patient safety and have received numerous awards and recognitions from some of the most prestigious institutions in the country for our leadership and exceptional patient outcomes. As an accountable care organization, we foster long-term patient-provider relationships that help promote preventive care, increase wellness and healthy behaviors, decrease emergency episodes, and prevent hospitalizations. To learn more: [ Ссылка ]
